The Canadian Pharmaceutical Manufacturers and Exporters Alliance (CPMEA) welcomes Health Canada's new pilot project to prioritize generic drug submissions from Canadian manufacturers. The initiative aims to accelerate access to essential medicines, strengthen domestic pharmaceutical manufacturing, improve supply resilience, and support Canada's long-term pharmaceutical sovereignty.

The Canadian Pharmaceutical Manufacturers and Exporters Alliance (CPMEA) congratulates Prime Minister Mark Carney on his historic win and looks forward to working with the new government to strengthen Canada’s pharmaceutical manufacturing sector, support public health, and drive economic growth through innovation, resilience, and a secure domestic supply of medicines.

CPMEA applauds Ontario's $146M investment in Life Science Strategy, boosting local pharmaceutical production and supply security.

CPMEA supports Canada's new Health Emergency Readiness agency, a vital step in securing medicine supply and boosting domestic production.